Role of drug metabolic enzymes and transporters in drug-drug interactions between antiretroviral and antituberculosis drugs

Abstract

Drug-drug interactions is one of the major determinant in drug development and clinical applications. Individual differences in pharmacokinetics may cause extensive variability in drug efficacy, toxicity and adverse drug reactions, and represent a major concern in drug development. According to world health organization, an estimated 1.2 million patients were diagnosed with HIV/TB coinfection in 2015, and approximately 400,000 coinfected individuals were died in 2016. During treatment of tuberculosis and human immunodeficiency virus (HIV) coinfections, a combination of multiple therapeutic drugs is used, which is potential for interactions between coadministered drugs. Drug metabolizing enzymes and transporters plays vital role in the disposition, pharmacokinetics as well as efficacy and toxicity of many antituberculosis (anti-TB) and antiretroviral (ARVs) drugs. The current understanding of drug-drug interactions involving the first-line antituberculosis and antiretroviral (ARVs) drugs are reviewed and summarized in this article emphasizing the role of drug transporters and metabolic enzymes. It is found that several clinical drug-interactions are caused by the phase I and II metabolic enzymes (cytochrome-P-450s, CYPs, UDP-glucuronosyltransferases, UGTs) and uptake/ efflux transporters, particularly permeability glycoprotein, brest cancer resistance protein, multidrug resistance protein and solute carrier transporters). Overall, this study will be helpful to understand the drug-interactions between the ARV or anti-TB drug regimen or with concomitantly used drugs at a glance. By understanding the unique functions and characteristics of enzymes and transporters, it may use in the management of drug interactions in the treatment of HIV and TB.

Authors and Affiliations

Md Masud Parvez, Nazia Kaisar, Jae-Gook Shin

Keywords

Related Articles

Analysis of telomere length in the coronary artery to determine the pathogenesis of coronary artery disease

Endothelial dysfunction is one of the earliest pathological features in atherosclerosis. The current study designed to analyse the telomere length of human coronary artery derived endothelial cells to identify the rela...

A brief review on Japanese Encephalitis in Swine with its diagnostic strategies

Japanese encephalitis is a viral disease affecting humans, mostly the children and is a major concern to public health. The single stranded flavivirus is mainly transmitted by mosquitoes of the Culex genus and causes n...

Long term administration of gentamicin affects hemato-biochemical parameters and liver architecture of Swiss Albino mice

Gentamicin is most frequently used aminoglycoside antibiotic. Despite its wide use, the effects of gentamicin have not been clearly studied in relation to alteration of hemato-biochemical parameters and liver injury. I...

The possible regulations through cross-generation transmission on childhood obesity

Obesity and overweight are considered as one of the top health problem worldwide, obesity may induce both physical and mental health consequences [1, 2]. Obesity and overweight is regulated by both genetics and environme...

A protein isolation method for western blot to study histones with an internal control protein

Histone modification is one of the attractive targets for epigenetic studies. However, current methods to extract chromatin-associated proteins for western blot of histone modification have some weaknesses such as the...

Download PDF file
  • EP ID EP36334
  • DOI -
  • Views 419
  • Downloads 0

How To Cite

Md Masud Parvez, Nazia Kaisar, Jae-Gook Shin (2018). Role of drug metabolic enzymes and transporters in drug-drug interactions between antiretroviral and antituberculosis drugs. Journal of Advanced Biotechnology and Experimental Therapeutics, 1(1), -. https://europub.co.uk/articles/-A-36334